Literature DB >> 20633831

ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

David R Holmes, Gregory J Dehmer, Sanjay Kaul, Dana Leifer, Patrick T O'Gara, C Michael Stein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633831     DOI: 10.1016/j.jacc.2010.05.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  96 in total

Review 1.  2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician.

Authors:  Nanette K Wenger
Journal:  Clin Cardiol       Date:  2011-12-06       Impact factor: 2.882

Review 2.  Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.

Authors:  Megan M Donohue; David L Tirschwell
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

3.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 4.  Personalized medicine: is it a pharmacogenetic mirage?

Authors:  Rashmi R Shah; Devron R Shah
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

Review 5.  Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Authors:  Thomas O Bergmeijer; Jean-Luc Reny; Ruth E Pakyz; Li Gong; Joshua P Lewis; Eun-Young Kim; Daniel Aradi; Israel Fernandez-Cadenas; Richard B Horenstein; Ming Ta Michael Lee; Ryan M Whaley; Joan Montaner; Gian Franco Gensini; John H Cleator; Kiyuk Chang; Lene Holmvang; Willibald Hochholzer; Dan M Roden; Stefan Winter; Russ B Altman; Dimitrios Alexopoulos; Ho-Sook Kim; Jean-Pierre Déry; Meinrad Gawaz; Kevin Bliden; Marco Valgimigli; Rossella Marcucci; Gianluca Campo; Elke Schaeffeler; Nadia P Dridi; Ming-Shien Wen; Jae Gook Shin; Tabassome Simon; Pierre Fontana; Betti Giusti; Tobias Geisler; Michiaki Kubo; Dietmar Trenk; Jolanta M Siller-Matula; Jurriën M Ten Berg; Paul A Gurbel; Jean-Sebastien Hulot; Braxton D Mitchell; Matthias Schwab; Marylyn DeRiggi Ritchie; Teri E Klein; Alan R Shuldiner
Journal:  Am Heart J       Date:  2017-12-17       Impact factor: 4.749

Review 6.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

7.  Assessment of the pharmacogenomics educational needs of pharmacists.

Authors:  Kristen B McCullough; Christine M Formea; Kevin D Berg; Julianna A Burzynski; Julie L Cunningham; Narith N Ou; Maria I Rudis; Joanna L Stollings; Wayne T Nicholson
Journal:  Am J Pharm Educ       Date:  2011-04-11       Impact factor: 2.047

8.  'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine.

Authors:  Jorge Duconge; Gualberto Ruaño
Journal:  Pharmacogenomics       Date:  2012-07       Impact factor: 2.533

9.  Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population.

Authors:  Carmelo Orengo-Mercado; Bianca Nieves; Lizbeth López; Nabila Vallés-Ortiz; Jessicca Y Renta; Pedro J Santiago-Borrero; Carmen L Cadilla; Jorge Duconge
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2013-03-27

10.  Clopidogrel: a pharmacogenomic perspective on its use in coronary artery disease.

Authors:  Chris Terpening
Journal:  Clin Med Insights Cardiol       Date:  2010-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.